BRPI0813832A2 - Métodos para tratamento da ansiedade - Google Patents
Métodos para tratamento da ansiedadeInfo
- Publication number
- BRPI0813832A2 BRPI0813832A2 BRPI0813832-0A2A BRPI0813832A BRPI0813832A2 BR PI0813832 A2 BRPI0813832 A2 BR PI0813832A2 BR PI0813832 A BRPI0813832 A BR PI0813832A BR PI0813832 A2 BRPI0813832 A2 BR PI0813832A2
- Authority
- BR
- Brazil
- Prior art keywords
- treatment methods
- anxiety treatment
- anxiety
- methods
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Quinoline Compounds (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95014407P | 2007-07-17 | 2007-07-17 | |
| PCT/US2008/069428 WO2009012082A1 (en) | 2007-07-17 | 2008-07-08 | Methods for treating anxiety |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0813832A2 true BRPI0813832A2 (pt) | 2015-01-06 |
Family
ID=39810180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0813832-0A2A BRPI0813832A2 (pt) | 2007-07-17 | 2008-07-08 | Métodos para tratamento da ansiedade |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8211917B2 (pt) |
| EP (1) | EP2175850B1 (pt) |
| JP (1) | JP2010533720A (pt) |
| KR (1) | KR20100047261A (pt) |
| CN (1) | CN101778628B (pt) |
| AU (1) | AU2008276278A1 (pt) |
| BR (1) | BRPI0813832A2 (pt) |
| CA (1) | CA2693369A1 (pt) |
| ES (1) | ES2621160T3 (pt) |
| NZ (1) | NZ582874A (pt) |
| RU (1) | RU2491931C2 (pt) |
| WO (1) | WO2009012082A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE549020T1 (de) | 2005-01-26 | 2012-03-15 | Allergan Inc | Pharmazeutische zusammensetzungen enthaltend 1- benzyl-1- hydroxy-2,3-diamino-propylamine, 3- benzyl-3 hydroxy-2-amino-propionsäureamide und verwandte verbindungen als analgetika |
| IN2012DN01209A (pt) * | 2009-07-17 | 2015-04-10 | Allergan Inc | |
| AU2010295698A1 (en) * | 2009-09-16 | 2012-04-12 | Allergan, Inc. | Compositions and methods for treating disorders of gastrointestinal motility |
| US8242141B2 (en) | 2009-09-16 | 2012-08-14 | Allergan, Inc. | Compositions and methods for treating seizure disorders |
| JP2013505246A (ja) * | 2009-09-16 | 2013-02-14 | アラーガン インコーポレイテッド | 痙縮を治療するための化合物及び方法 |
| CA2884926C (en) * | 2012-10-15 | 2021-09-21 | Orion Corporation | A veterinary method of alleviating noise aversion |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6071970A (en) * | 1993-02-08 | 2000-06-06 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| RU2235092C2 (ru) * | 1997-12-04 | 2004-08-27 | Оллерган Инк. | Замещенные производные имидазола, способ введения активного соединения и способ лечения на основе этих соединений |
| WO2003045928A1 (en) | 2001-11-26 | 2003-06-05 | Genzyme Corporation | Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors |
| PT1558582E (pt) * | 2003-07-22 | 2006-05-31 | Arena Pharm Inc | Derivados de diaril- e aril-heteroaril-ureia como moduladores do receptor de serotonina 5-ht2a uteis para a profilaxia e tratamento de desordens relacionadas com o mesmo |
| JP4766393B2 (ja) * | 2004-01-06 | 2011-09-07 | 大正製薬株式会社 | トリアザ−シクロペンタ［ｃｄ］インデン誘導体 |
| ATE549020T1 (de) | 2005-01-26 | 2012-03-15 | Allergan Inc | Pharmazeutische zusammensetzungen enthaltend 1- benzyl-1- hydroxy-2,3-diamino-propylamine, 3- benzyl-3 hydroxy-2-amino-propionsäureamide und verwandte verbindungen als analgetika |
| US20100105687A1 (en) * | 2007-03-06 | 2010-04-29 | Allergan, Inc. | Methods for treating cognitive disorders using 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds |
| WO2008109285A1 (en) * | 2007-03-06 | 2008-09-12 | Allergan, Inc. | Methods for treating cognitive disorders |
| JP2010520299A (ja) | 2007-03-06 | 2010-06-10 | アラーガン、インコーポレイテッド | ３−アリール−３−ヒドロキシ−２−アミノ−プロピオン酸アミド、３−ヘテロアリール−３−ヒドロキシ−２−アミノ−プロピオン酸アミドおよび関連化合物を使用する認知障害の処置方法 |
| WO2008109287A1 (en) | 2007-03-06 | 2008-09-12 | Allergan, Inc. | Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds |
-
2008
- 2008-07-08 JP JP2010517073A patent/JP2010533720A/ja active Pending
- 2008-07-08 US US12/669,304 patent/US8211917B2/en active Active
- 2008-07-08 CA CA2693369A patent/CA2693369A1/en not_active Abandoned
- 2008-07-08 KR KR1020107003376A patent/KR20100047261A/ko not_active Application Discontinuation
- 2008-07-08 EP EP08781509.8A patent/EP2175850B1/en active Active
- 2008-07-08 WO PCT/US2008/069428 patent/WO2009012082A1/en active Application Filing
- 2008-07-08 ES ES08781509.8T patent/ES2621160T3/es active Active
- 2008-07-08 AU AU2008276278A patent/AU2008276278A1/en not_active Abandoned
- 2008-07-08 NZ NZ582874A patent/NZ582874A/en not_active IP Right Cessation
- 2008-07-08 CN CN2008801024044A patent/CN101778628B/zh not_active Expired - Fee Related
- 2008-07-08 BR BRPI0813832-0A2A patent/BRPI0813832A2/pt not_active IP Right Cessation
- 2008-07-08 RU RU2010105135/15A patent/RU2491931C2/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US8211917B2 (en) | 2012-07-03 |
| EP2175850A1 (en) | 2010-04-21 |
| RU2491931C2 (ru) | 2013-09-10 |
| NZ582874A (en) | 2012-06-29 |
| KR20100047261A (ko) | 2010-05-07 |
| JP2010533720A (ja) | 2010-10-28 |
| EP2175850B1 (en) | 2017-01-11 |
| CN101778628A (zh) | 2010-07-14 |
| ES2621160T3 (es) | 2017-07-03 |
| RU2010105135A (ru) | 2011-08-27 |
| WO2009012082A1 (en) | 2009-01-22 |
| US20100197730A1 (en) | 2010-08-05 |
| CA2693369A1 (en) | 2009-01-22 |
| AU2008276278A1 (en) | 2009-01-22 |
| CN101778628B (zh) | 2013-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0908260A2 (pt) | Dispositivo para tratamento térmico | |
| BRPI0819076A2 (pt) | aparelho para tratamento de água | |
| BRPI0906748A2 (pt) | Aparelho para tratamento da obesidade | |
| BRPI0818056A2 (pt) | Aparelho e métodos para hemodiálise | |
| BRPI0817870A2 (pt) | dispositivo para tratamento de aneurisma | |
| BRPI0811752A2 (pt) | Aparelho para tratar gás | |
| BRPI0915476A2 (pt) | dispositivo para tratar problemas respiratórios | |
| BRPI0813725A2 (pt) | Métodos e composições para tratamento de doenças | |
| BRPI0908026A2 (pt) | Métodos para o tratamento de doenças do intestino | |
| DE602008004806D1 (de) | Erhitzungsvorrichtung | |
| BRPI0910259A2 (pt) | métodos de tratamento de inflamação | |
| BRPI0814359A2 (pt) | Método | |
| BRPI0817226A2 (pt) | Método | |
| BRPI0817726A2 (pt) | Método | |
| DK2175851T3 (da) | Biofilmbehandling | |
| BRPI0910854A2 (pt) | métodos de tratamento | |
| BRPI0813670A2 (pt) | Compostos para tratamento | |
| BRPI0908715A2 (pt) | métodos para tratamento da psoríase | |
| DK2361116T3 (da) | Bestrålingsindretning | |
| BRPI0919127A2 (pt) | métodos para tratamento de água | |
| BR112012011730A2 (pt) | tratamentos para distúrbios gastrointestinais | |
| DK2330887T3 (da) | Behandlingsindretning | |
| BRPI0922871A2 (pt) | metodos para o tratamento da esclerose múltipla usando pirazinoindóis tetracíclicos | |
| DK2173831T3 (da) | Brøndbehandling | |
| BRPI0822849A2 (pt) | Aparelho para cirurgia oftalmológica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |